BioCentury
ARTICLE | Financial News

G1 prices $180M follow-on

September 21, 2018 4:30 PM UTC

G1 Therapeutics Inc. (NASDAQ:GTHX) raised $180 million in a follow-on that priced after hours on Sept. 18.

G1 sold 3 million shares at $60 in an offering underwritten by J. P. Morgan, Cowen, Needham, Wedbush, BTIG and H.C. Wainwright. The price is an 11% discount to the company’s close of $66.40 on Sept. 17, before proposing the offering after hours. G1 slipped 5% on Sept. 18 before pricing the offering, and was off another $2.94 to $60 on Sept. 19...